Skip to main content
SpringerLink
Log in

A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Optimal histologic criteria for the classification of and grading of ependymomas, including their anaplastic forms, remain elusive. This is especially true because of the poor correlation of these criteria with clinical outcome. The aim of this study was to identify the histopathologic parameters that could distinguish different prognostic groups of patients with ependymomas. Eighty-one patients with ependymal tumors, including those originally diagnosed ependymomas, anaplastic ependymomas and myxopapillary ependymomas, were enrolled in this study. Thirteen histologic parameters, including hypercellularity, nuclear pleomorphism, mitoses, endothelial proliferation, necrosis, clear cell, thrombi, dystrophic calcification, psammoma bodies, bone, cartilage, Rosenthal fibers and MIB-1 labeling index (LI), were evaluated in each patient and correlated with clinical outcome. We assigned one score for each histopathologic parameter evaluated and used a stepwise selection method with entry model based on the significance of the log-rank statistic to formulate a scoring model. Four parameters were chosen in this process, including mitoses ≥ 4/10 hpf (1.7/mm2), hypercellularity, endothelial proliferation and necrosis. The sum of these four parameters (scores) was the histopathologic score of the tumor. The progression-free survival (PFS) and overall survival (OS) of patients with histopathologic scores 0 and 1 were significantly better than those with histopathologic scores 2, 3 and 4 (p < 0.001 and p = 0.005, respectively). Because of the latter finding, we proposed that anaplastic ependymoma could be diagnosed by the presence of any two of the aforementioned four parameters. Multivariate analyses including clinical and histopathologic variables showed that histopathologic score ≥ 2 and subtotal resection were the factors related to increased risk of recurrence, while histopathologic score ≥ 2 was the only factor related to overall survival. Based on the above findings, we concluded that histopathology is an important prognostic indicator for patients with ependymomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kleihues P, Burger PC, Scheithauer BW: World Health Organization Histological Typing of Tumours of the Central Nervous System, 2nd edn. Springer-Verlag, New York, 1993, pp 17–19

    Google Scholar 

  2. Ernestus RI, Schröder R, Stützer H, Klug N: Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 12: 522–526, 1996

    Google Scholar 

  3. West CR, Bruce DA, Duffner PK: Ependymomas. Factors in clinical and diagnostic staging. Cancer 56: 1812–1816, 1985

    Google Scholar 

  4. Nazar GB, Hoffman HJ, Becker LE, Jenkin D, Humphreys RP, Hendrick EB: Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 72: 408–417, 1990

    Google Scholar 

  5. Gerszten PC, Pollack IF, Martinez AJ, Lo KH, Janosky J, Albright AL: Intracranial ependymomas of childhood: lack of correlation of histopathology and clinical outcome. Pathol Res Pract 192: 515–522, 1996

    Google Scholar 

  6. Foreman NK, Love S, Thorne R: Intracranial ependymomas: analysis of prognostic factors in a population-based series. Pediatr Neurosurg 24: 119–125, 1996

    Google Scholar 

  7. Rawlings CE 3rd, Giangaspero F, Burger PC, Bullard DE: Ependymomas: a clinicopathologic study. Surg Neurol 29: 271–281, 1988

    Google Scholar 

  8. Ross GW, Rubinstein LJ: Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 70: 31–36, 1989

    Google Scholar 

  9. Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M: Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37: 655–667, 1995

    Google Scholar 

  10. Bouffet E, Perilongo G, Canete A, Massimino M: Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol 30: 319–331, 1998

    Google Scholar 

  11. Zülch KJ: Brain Tumors: Their Biology and Pathology, 3rd edn. Springer-Verlag, Berlin Heidelberg, 1986, pp 258–276

    Google Scholar 

  12. Ferrante L, Mastronardi L, Celli P, Lunardi P, Acqui M, Fortuna A: Intramedullary spinal cord ependymomas a study of 45 cases with long-term follow-up. Acta Neurochir (Wien) 119: 74–79, 1992

    Google Scholar 

  13. Sonneland PR, Scheithauer BW, Onofrio BM: Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer 56: 883–893, 1985

    Google Scholar 

  14. Asai A, Hoshino T, Edwards MS, Davis RL: Predicting the recurrence of ependymomas from the bromodeoxyuridine labeling index. Childs Nerv Syst 8: 273–278, 1992

    Google Scholar 

  15. Rorke LB: Relationship of morphology of ependymoma in children to prognosis. Prog Exp Tumor Res 30: 170–174, 1987

    Google Scholar 

  16. Figarella-Branger D, Gambarelli D, Dollo C, Devictor B, Perez-Castillo AM, Genitori L, Lena G, Choux M, Pellissier JF: Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases. Acta Neuropathol (Berl) 82: 208–216, 1991

    Google Scholar 

  17. Schröder R, Ploner C, Ernestus RI: The growth potential of ependymomas with varying grades of malignancy measured by the Ki-67 labelling index and mitotic index. Neurosurg Rev 16: 145–150, 1993

    Google Scholar 

  18. Ritter AM, Hess KR, McLendon RE, Langford LA: Ependymomas: MIB-1 proliferation index and survival. J Neuro Oncol 40: 51–57, 1998

    Google Scholar 

  19. Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet J-C, Lena G, Choux M, Pellissier JF: Prognostic factors in intracranial ependymomas in children. J Neurosurg 93: 605–613, 2000

    Google Scholar 

  20. Viberti L, Papotti M, Abbona GC, Celano A, Filosso PL, Bussolati G:Value of Ki-67 immunostaining in preoperative biopsies of carcinomas of the lung.Hum Pathol 28: 189–192, 1997

    Google Scholar 

  21. Jansen RL, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Schouten HC, Hillen HF: MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer 78: 460–465, 1998

    Google Scholar 

  22. Abramovich CM, Prayson RA: MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 29: 1420–1427, 1998

    Google Scholar 

  23. Ho DM, Wong TT, Hsu CY, Ting LT, Chiang H: MIB-1 labeling index in nonpilocytic astrocytoma of childhood. A study of 101 cases. Cancer 82: 2459–2466, 1998

    Google Scholar 

  24. Prayson RA: Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity. Mod Pathol 10: 304–310, 1997

    Google Scholar 

  25. Rushing EJ, Brown DF, Hladik CL, Risser RC, Mickey BE, White CL 3rd: Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Mod Pathol 11: 464–470, 1998

    Google Scholar 

  26. Bennetto L, Foreman N, Harding B, Hayward R, Ironside J, Love S, Ellison D: Ki-67 immunolabelling index is a prognostic indicator in childhood posterior fossa ependymomas. Neuropathol Appl Neurobiol 24: 434–440, 1998

    Google Scholar 

  27. Prayson RA: Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.Am J Clin Pathol 110: 629–634, 1998

    Google Scholar 

  28. Prayson RA: Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry. Ann Diagn Pathol 3: 11–18, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Taiwan

    Donald Ming-Tak Ho, Chih-Yi Hsu & Hung Chiang

  2. Department of Pathology, National Yang-Ming University School of Medicine, Taiwan, R.O.C

    Donald Ming-Tak Ho, Chih-Yi Hsu & Hung Chiang

  3. Division of Pediatric Neurosurgery, Neurological Institute, Veterans General Hospital-Taipei, Taiwan, R.O.C.

    Tai-Tong Wong

  4. Department of Surgery, National Yang-Ming University School of Medicine, Taiwan, R.O.C

    Tai-Tong Wong

Authors
  1. Donald Ming-Tak Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chih-Yi Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tai-Tong Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hung Chiang
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ming-Tak Ho, D., Hsu, CY., Wong, TT. et al. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma. J Neurooncol 54, 77–85 (2001). https://doi.org/10.1023/A:1012590505236

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012590505236

Search

Navigation